TP53 and malignant colon neoplasm: In addition, they indicate that inhibition of one isoform is sufficient to bypass drug resistance of p53-null colon cancer cells since both GSK3 isoforms negatively regulate the RIP1-independent necroptotic response elicited by chemotherapy.